TABLE 1.

Study population demographics (modified from ¹⁴ )

	Number of patients	Mean ± SD
Age (years)	5	64 ± 5
Disease duration since diagnosis	5	8 ± 5
MDS‐UPDRS III score	5	20 ± 5
Sex (male)	5	–
Carbidopa‐Levodopa 25–100 mg a	3	–
Carbidopa‐Levodopa 50–200 mg	1	–
Carbidopa‐Levodopa 23–95 mg	1	–

Values are depicted as mean ± SD.

^aSubject 2001 started anti‐parkinsonian therapy on month 8.